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Abstract
Background: Substance users being admitted to inpatient treatment experience a high level of mental distress. In
this study we explored changes in mental distress during treatment.
Methods: Mental distress, as measured by the HSCL-10, was registered at admission and at discharge among 164
substance users in inpatient treatment in Northern Norway. Predictors of reduction in mental distress were
examined utilizing hierarchical regression analysis.
Results: We found a significant reduction in mental distress in the sample, but the number of patients scoring
above cut-off on the HSCL-10 at discharge was still much higher than in the general population. A more severe
use of substances as measured by the AUDIT and the DUDIT, and being female, predicted a higher level of mental
distress at admission to treatment as well as greater reduction in mental distress during treatment. Holding no
education beyond 10 year compulsory school only predicted a reduction in mental distress.
Conclusions: The toxic and withdrawal effects of substances, level of education as well as gender, contributed to
the differences in change in mental distress during treatment. Regression to the mean may in part explain some of
the findings.
Background
In studies of the general population, the incidence of men-
tal disorders among people with substance use disorders
(SUD) varies according to catchment area and methodol-
ogy. It is assumed that 30 - 40% of people with alcohol
related disorders, and 40 - 50% of people with other SUD,
also have a psychiatric disorder [1-5]. The incidence of
psychiatric disorders among individuals with SUD in treat-
ment is even higher [6,7]. Psychiatric disorders have
repeatedly been shown to influence treatment outcomes
in different treatment seeking SUD samples [8-10].
The psychiatric disorders most commonly associated
with SUD are anxiety and depression [11-13]. Symptoms
of anxiety and depression have been found to influence
the course of treatment [10], and to predict relapse in
SUD [14-16]. On the other hand, several studies have
found that anxiety and depressive symptoms among SUD
patients often are passing, representing toxic or withdra-
wal effects that resolve in response to abstinence or to
entry into SUD treatment [17-21]. Longitudinal studies
in representative population samples suggest that casual
relationships can operate in various directions between
SUD and symptoms of anxiety and depression [22]. Anxi-
ety and depression could increase the likelihood of devel-
oping SUD; the development of SUD among those with
anxiety and depressive symptoms could worsen their
course, and symptoms of anxiety and depression could
reflect substance-induced conditions [23]. Previous stu-
dies of SUD treatment have shown that patients who stay
in treatment longer more likely achieve the best out-
comes, regardless of outcome measures [20,24].
In screening for psychiatric disorders, the concept of
mental distress is widely used. One screening instru-
ment used in population studies is the HSCL-10 [25].
The HSCL-10 has been developed from the original
HSCL-90 [26], using two (i.e. anxiety and depression)
out of the nine original dimensions [27]. In the general
population, it has been found that 11.4% of the popula-
tion meets the criteria for further assessment and treat-
ment of psychiatric disorders [25]. In one study, it was
c o n c l u d e dt h a t5 0-6 0 %o ft h e“cases” identified by
instruments like the HSCL-10 meet the criteria for a
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have described a close relation between substance use
and mental distress [29,30].
Epidemiological surveys have consistently documented
higher rates of anxiety and depression among women than
men [31,32], and it is a common finding that women
report a higher level of mental distress [33]. In a treatment
seeking sample of patients with SUD in Norway, women
more often suffered from depression than men [6]. In a
follow-up of the same sample six years after treatment,
Bakken et al. [34] found that mental distress remained
high at the time of follow-up, and that abstainers had a
significantly lower level of mental distress, especially
female abstainers. This finding is consistent with other
studies that have shown that women in SUD treatment
generally report a higher level of mental distress [35].
In the general population, higher education is known
as a protective factor with respect to physical and men-
tal health [36,37]. A Norwegian population study con-
cluded that a higher level of education seemed to have a
protective effect against anxiety and depression [38]. In
Norway, more than 80% of the population hold an edu-
cation beyond 10 year compulsory school [39]. There is
a consistent relationship between dropping out of high
school and substance use [40]. In one study, it was
found that drop-outs used substances at elevated levels
compared with in-school peers, and the drop-outs were
more likely to develop alcohol related disorders [41]. In
another study, drop-out from school in Norway was
shown to be related to frequent alcohol intoxications
[42]. Typically, those in lower socio-economic groups
have worse health and higher mortality than those in
higher socio-economic groups [43,44]. SUD and other
psychiatric disorders are generally associated with a vari-
ety of psychosocial risk factors [45-48].
I nar e c e n ts t u d y[ 3 0 ] ,w ee x a m i n e dp r e d i c t o r so fm e n t a l
distress at admission to in-patient SUD treatment. This
study indicated that gender had a significant impact on
the level of mental distress, as women scored higher on
mental distress at admission to treatment. A more severe
use of substances, as reported on the AUDIT [49] and the
DUDIT [50], also predicted a higher level of mental dis-
tress, as well as having previously received psychiatric
treatment. In this study, 83% of the patients scored above
the established cut-off for the HSCL-10 at admission.
The aim of the present study was to determine predic-
tors of change in the level of mental distress among
SUD patients in inpatient treatment. First, we examined
to which extent mental distress changed during treat-
ment. Second, we examined possible determinants of
the change in mental distress.
Material and methods
This is the first study on substance use, mental distress
and treatment outcomes in Northern Norway including
patients in several units. The project was based on a
naturalistic design with measurements taken before
treatment and at discharge. All patients admitted to the
units and considered competent to consent during the
period September 2007 to May 2009 were given written
and oral information about the study by a research col-
laborator working in each unit.
Material
Data was collected from 164 patients admitted to one of
the five inpatient treatment units for SUD use within the
catchment area of the University Hospital of Northern
Norway. In the study period, 574 patients were admitted
to the units. Patients who were considered not able to
give an informed consent (N = 21) or whose hospital stay
was too short too be included (N = 41) were not asked to
participate. Of the patients considered relevant for the
study (N = 512), 296 patients (58%) agreed to participate
and signed an informed consent. Of these, 273 patients
filled out the questionnaire at admission, and of these
172 filled out the questionnaire at discharge. Patients (N
= 8), who had failed to complete the HSCL-10 in both of
the questionnaires, were excluded from the analyses.
None of the patients’ replies deviated strongly statisti-
cally. The final sample thus consisted of 164 respondents
(74% men, mean age 40, range 18 - 67 years). More than
90% of the sample had a Norwegian origin.
As only two percent of patients from the catchment
area were referred to outpatient treatment in 2005
[51], the inpatient group was highly representative of
all patients. The units covered a population of 500 000
inhabitants in the counties of Nordland, Troms and
Finnmark. Unit 1 offered specialized assessment and
treatment of dual diagnoses and provided treatment up
to six months (N = 12) Unit 2 provided treatment up
to 18 months according to a therapeutic community
model (N = 9). Unit 3 was a detoxification unit that
provided treatment up to six weeks (N = 54). Unit 4
and 5 provided general SUD inpatient treatment up to
six months (N =4 3a n dN = 48). All units treated
both sexes, used a combination of group and individual
therapy, and managed detoxification directly (Unit 2
and 3) or in collaboration with a detoxification unit
(Unit 1, 4 and 5). Treatment was composed of a com-
bination of network-based approaches, psychothera-
peutic and pharmacological treatments, but these
components were given different emphasis in the var-
ious units.
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Outcome
Mental distress Mental distress was measured twice,
before admission and at discharge, using a 10 item ver-
sion of the Hopkins Symptom Check-List (HSCL-10)
[25]. The HSCL-10 is a self-report questionnaire with a
four point Likert scale, ranging from 1 (not at all) to 4
(extremely). The HSCL-10 is based on the SCL-90-R
[26], and is composed of two out of the original nine
factors (anxiety and depression) [27]. A mean item score
was calculated and used as an index of general distress
severity. Missing data were replaced with the mean
value if no more than two item scores were missing
[52]. An average score of 1.85 or higher indicates a need
of further assessment and possibly a need for psychiatric
treatment [25].
Improvement in mental distress during treatment
Improvement was measured as a reduction in the mean
HSCL-10 scores from pre to post. Change scores were
calculated by subtracting the mean post score from the
mean pre score. As the purpose of using change scores
in the present study was to identify predictors of
change, rather than evaluating absolute change, the
reliability of change scores may be estimated with Cron-
bach’s method [53]. The internal consistency of the
change scores was very good (a = .84), while the relia-
bility of the pre- and post-test scores were comparable
(a = .91).
Predictors
Alcohol and drug use Substance use was measured by
the Alcohol Use Disorders Identification Test (AUDIT)
[54] and the Drug Use Disorders Identification Test
(DUDIT) [55]. The AUDIT is a widespread instrument
measuring severity of alcohol use the past 12 months. It
has 10 items with a scoring range from 0 to 40. The
DUDIT is a parallel instrument to the AUDIT and is
designed to identify persons with drug use problems the
past 12 months. It has 11 items with a scoring range
from 0 to 44.
Current use of specific substances were measured by
the self-report Drug Use Disorders identification Test -
Extended (DUDIT-E) [56]. Responses to the DUDIT-E
were coded 0 if a substance was used less than twice a
month, and 1 if used twice a month or more often [57].
The number of substances used was calculated from the
number of substances used twice a month or more as
reported on the DUDIT-E, together with alcohol used
twice a week or more as reported on the AUDIT.
Variables related to admission and discharge The
patients’ socio-demographic and treatment histories
were assessed using the Norwegian National Client
Assessment Form [58]. Variables in this form include
age, sex, occupation, housing, and previous treatment.
This form is routinely completed for all patients
admitted to SUD treatment in Norway. In addition, the
patients’ clinicians provided extended information on
the patients’ socio-demographic history and diagnostic
assessment through a form developed especially for this
study.
The patients stayed in treatment for an average of 56
days (range 3 - 396). The variable defining the treatment
setting was dichotomized into the detoxification unit
(N = 54) and all other units (N = 110).
The kind of treatment offered to the patients was
registered on a form listing 18 possible treatments, e.g.
individual treatment by a clinical psychologist, psycho-
tropic medication, group treatment and family
counseling.
Procedures
Shortly following their consent to participate they
responded to the questionnaire. Before discharge,
patients responded to a second questionnaire including
corresponding questions, as well as questions about
treatment satisfaction. Patients were paid compensation
in the form of a cinema ticket or two lottery tickets
(worth $8). The study was approved by the Regional
Committee for Medical Research Ethics (P REK Nord
12/2006) and the Norwegian Social Science Data Ser-
vices (NSD).
Statistical Methods
All analyses were conducted using SPSS 16.0. Internal
consistency of test scores were assessed with Cronbach’s
alpha [53]. A hierarchical regression analysis was con-
ducted to identify predictors of HSCL-10 change scores
[59]. The predictors were entered in the regression
model in three steps: 1) demographic variables (age,
gender, employment, marital status, living conditions,
and education), 2) substanc eu s e( s c o r eo nA U D I Ta n d
DUDIT, number of substances used), and 3) treatment
variables (previous substance use or psychiatric treat-
ment, number of days in treatment, treatment in the
detoxification unit (Unit 3), psychotropic medical treat-
ment, and treatment by clinical psychologist). As we did
not have a clear theory or other empirical studies done
in Norway to guide the selection of variables within
each cluster (block) of predictors, a stepwise procedure
was used. Regression diagnostics were performed to test
for collinearity, normality, outliers, and leverage. Effect
size statistics were reported as Cohen’s d (paired
t-tests). According to Cohen [ 6 0 ] ,e f f e c ts i z e so f. 2 ,. 5
and .8 represent weak, moderate and strong effects,
respectively.
Results
T h em o s tf r e q u e n t l yo c c u r r i n gs u b s t a n c eu s ep r o b l e m ,
according to diagnoses reported by the clinicians, was
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dependence to hypnotics (20%), and amphetamine
dependence (19%). Concurrent polydrug use was com-
mon as 64% reported using two or more substances,
and 42% using three or more substances.
Reduction in Mental Distress
On average, the participating patients reported a high
mean score of mental distress at admission (M =2 . 5 4 ,
SD = .75), which decreased during treatment, being sig-
nificantly lower (M = 1.86, SD = .67) at discharge (t163 =
13.24, p < 0.001). The statistical effect size of this reduc-
tion was very strong (d = 1.14). The proportion of
patients scoring above the established cut-off-level of
1.85 on HSCL-10 fell from 82% at admission to 44% at
discharge.
Predictors of change in Mental Distress
The mean and the standard deviation of mental distress
change scores were -.68 and .66, respectively. Among
the 164 patients, 141 patients reported a reduction in
distress (max positive change: -2.80), while 4 patients
reported no change and 19 patients reported a negative
change by experiencing more mental distress at dis-
charge (max negative change: 1.30). In order to identify
which factors that were related to improvement during
treatment, a hierarchical regression analysis was con-
ducted on the change scores in mental distress. The
standardized regression coefficients are presented in
Table 1. Demographic variables were entered into
the first step. Two of the six variables contributed sig-
nificantly. Education explained 3.1% of the variance
(Adj R
2)( F1, 162 = 6.21, p = 0.014), indicating that hav-
ing no education exceeding 10 year compulsory school,
was related to a larger reduction in HSCL-scores.
Gender explained an additional 2.6% of the variance
(F-change1, 161 =4 . 4 8 ,p = 0.036), indicating that
women experienced a larger reduction in HSCL-10
scores. In the second step three substance use variables
were entered, and two of these contributed significantly.
Variation in the AUDIT scores explained an additional
3.0% of the variance (F-change1, 160 = 5.47, p = 0.021),
and variation in the DUDIT scores explained an addi-
tional 4.3% of the variance (F-change1, 159 = 7.75, p =
0.006), indicating that a more severe use of alcohol and
other substances was related to more reduction in
HSCL-10 scores. In the third step, none of the variables
related to type of treatment contributed significantly.
The final regression coefficient parameters with HSCL-
10 change scores as the criterion variable are shown in
Table 1.
Discussion
The present study demonstrated that mental distress
changed significantly during treatment for patients
admitted to inpatient SUD treatment. A lower level of
education, being female and having a more severe use of
substances, all predicted a greater change in mental dis-
tress during treatment. Being female and having a more
severe use of substances were also connected to a higher
level of mental distress at admission to treatment [30].
Even though change in mental distress from admission
to discharge was substantial in this sample, the level of
mental distress was still high at discharge. Almost half
of the sample scored above cut-off on the HSCL-10, as
opposed to 11.4% in the general population in Norway
[25]. Regression to the mean may in part explain some
of the findings. It is a well known fact that the people
that have the highest scores (or the most problems) also
are in the position to change most. Despite this, a score
of change like the one that is used in this study has
been shown to be highly reliable [61].
A more severe use of substances predicted a larger
reduction in mental distress during treatment. This could
mean that mental distress is connected to the use of sub-
stances, and that these symptoms decrease as use of sub-
stances decrease and symptoms of intoxication and
withdrawal vanish. This assumption is supported by pre-
vious studies which have shown that psychiatric symp-
toms like depression and anxiety to a great extent change
after some time in treatment [17,21]. Moreover, some
depressive symptoms resolve rapidly after brief periods of
abstinence or entry into SUD treatment [18-20].
To some extent, symptoms of depression and anxiety
among SUD patients can be seen as toxic or withdra-
wal symptoms, and can therefore be expected to vanish
during treatment. Still, the proportion of patients with
a mental distress score above cut-off at discharge is
high - 44%. These findings are consistent with previous
studies of SUD treatment, which have shown that
patients who stay in treatment longer more likely
achieve the best outcomes, regardless of the outcome
measure [20,24]. This finding could be an argument
for offering treatment that is extended beyond the
withdrawal phase.
Table 1 Stepwise hierarchical regression analysis
predicting change in HSCL-10 scores (N = 164)
Step and predictor ßR
2 ΔR
2 Final ß
Step 1 .06 .06*
Education (1 = post
compulsory school)
-0.19* -0.21**
Gender (1 = men) -0.16* -0.17*
Step 2 0.11 0.07*
DUDIT 0.21** 0.28**
AUDIT 0.19* 0.19*
Note.*p < .05, ** p < .01.
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mental distress during treatment than men. As we
found in a prior study, there was also a significant dif-
ference in the level of mental distress between men and
women at admission to treatment [30]. It is a well
known fact from population studies that women report
a higher level of mental distress and qualify more often
for diagnoses of anxiety and depression [32,33]. The
finding from our study is consistent with prior results
[6,34], suggesting that women experience a higher
degree of mental distress and also a greater reduction in
mental distress if abstinent. This result could also reflect
the fact that SUD treatment in our area is more
adjusted to the needs of women.
A possibly surprising result in this study was that a
lower level of education (i.e. 10 year compulsory school
at the most) was associated with a greater change in
mental distress during treatment. Population studies
have found that those in lower socio-economic groups
in general have worse health and higher mortality than
those in higher socio-economic groups [43], and in the
general population the prevalence of mental distress has
been found to increase by decreasing social status [44].
A higher education level has been found to have a pro-
tective effect against anxiety and depression [38]. Educa-
tion is known as a factor that impacts physical health, in
the way that education may act to support positive life-
style choices and the development of habits that over
time maintain physical health [37]. A number of psycho-
social factors have been shown to be related to the
development of problematic substance use [46]. In our
study, it was only the difference between no education
beyond compulsory school and any further education
that was significant. 43% of the sample was in the group
that had no education beyond compulsory school. This
is a higher percentage than in the general Norwegian
population, where only 21% have no education beyond
compulsory school [39]. An early onset of SUD is
related to school drop-out [40-42]. The fact that patients
with less education experienced significantly more
reduction in mental distress than those with more edu-
cation could reflect that developing a SUD causes a
downward shift in socio-economic group [48], and in
this sense implies a greater loss of functions, a higher
sense of loss, and a greater degree of stigma for people
with more education than those with less. Further
research is necessary to understand this phenomenon,
for instance by conducting qualitative interviews of
patients, focusing on the content of treatment.
Strengths and limitations
The present study is subject to a number of limitations.
The study sample was selected from five different units
for inpatient SUD treatment. The units differed
substantially - one unit was primarily concerned with
detoxification, one unit focused on the assessment of
dual diagnosis patients, and three units offered a more
goal directed SUD treatment. There is, therefore, some
heterogeneity within the sample. The participation rate
was also relatively low. A proportion of the original par-
ticipants did not complete the survey at discharge. A
potential drawback with calculating change scores is the
risk of a marked reduction in test score reliability as
measurement errors at two points in time are added
together, hence increasing total measurement error. The
consequence is loss of statistical power. However, a sub-
stantial reduced reliability is not always the case, as was
demonstrated in a study using generalizability theory to
estimate absolute and relative reliability of change scores
[61]. If the variance in change scores and the number of
items are large enough, the reliability of change scores
may be adequately high. A further limitation can be that
the study lacks an untreated control condition, although
this is extremely difficult to construct in this study set-
ting. On the other hand, multisite, prospective studies
like the present can investigate treatment outcomes in
existing services and under actual clinical circumstances,
and thereby show a high external validity and allow for
a generalization of the findings to clinical settings [20].
Conclusions
Patients with SUD admitted to inpatient treatment
reported a significant reduction in mental distress
through treatment. An increased severity in the use of
substances, as well as being female, both predicted a
higher level of mental distress at admission to treatment
and a greater change in mental distress during treat-
ment. Holding no education beyond compulsory school
only predicted a reduction in mental distress during
treatment. The toxic and withdrawal effects of sub-
stances, level of education as well as gender, probably
explain most of the differences in change. Some of these
changes may in part be explained by regression to the
mean.
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